Global Constipation Market: Industry Analysis and Outlook (2017-2021)
Latest Report Available at Orbis research Constipation Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
(EMAILWIRE.COM, September 01, 2017 ) Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/402949 .
Constipation is a chronic medical condition which makes a person unable to pass fecal content properly. In this condition, the stool is often dry, hard and painful to pass. Bowel movements vary person to person but, if the bowel movement is missing for more than 3 days in adults and 4 days in children, then it is considered as constipation. Constipation can be of three types; irritable bowel syndrome-constipation (IBS-C), chronic idiopathic constipation and opioid-induced-constipation (OIC).
The U.S. is a major contributor to the global constipation market supported by rising opioid usage among chronic disease patients and increasing prescription drugs volumes. The U.S. is likely to experience further growth in constipation market with increasing ageing population and rapid development of new drugs in the market.
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
Purchase a copy of Constipation Market visit @ http://www.orbisresearch.com/contact/purchase/402949 For more information contact sales@orbisresearch.com .
The global constipation market is expected to grow in future with rising constipation prevalence, increasing ageing population, rise in health expenditure, mounting spinal cord injury patient population, growing spending on medicines and pharmaceutical R&D expenditure. Key trends of this market include progressing drugs under pipeline and adoption of unhealthy lifestyle. However, there are some factors which can hinder growth of the market including stringent regulations and low awareness of prescription drugs.
The report “Global Constipation Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Japan, China and Europe. The report profiles the key players of the market including Ironwood Pharmaceuticals Inc., Sucampo Pharmaceuticals Inc., Synergy Pharmaceuticals Inc. and ARDELYX Inc.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-constipation-market-industry-analysis-and-outlook-2017-2021 .
List Of Tables:
Types of Constipation
Current Treatment Options for Constipation
The U.S. Constipation Market by Value (2012-2016)
The U.S. Constipation Market by Type (2012-2016)
The U.S. Constipation Market Forecast by Value (2017-2021)
The U.S. Constipation Market Forecast by Type (2017-2021)
The U.S. Constipation Market by Drug (2016/2021)
The U.S. Constipation Branded Drugs Prescription Volume (2012-2016)
The U.S. Constipation Branded Drug Prescription Volume by Type (2012-2016)
The U.S. Constipation Patient Population Forecast (2016-2021)
Europe CIC Patient Population Forecast (2016-2021)
Europe IBS-C Patient Population Forecast (2016-2021)
Europe OIC Patient Population Forecast (2016-2021)
Europe Plecanatide Sales Forecast (2018-2021)
Japan Constipation Patient Population Forecast (2016-2021)
Japan Amitiza Sales Forecast (2016-2021)
China Constipation Patient Population Forecast (2016-2021)
China Amitiza Sales Forecast (2018-2021)
Global Ageing Population (2012-2016)
Global Healthcare Expenditure per Capita (2012-2016)
Global Spending on Medicines (2012-2016)
Global Spinal Cord Injury Patient Population (2012-2016)
Global Pharmaceutical R&D Spending (2013-2016)
Revenue Comparison of Key Players (2016)
Market Cap of Key Players (2016)
The U.S. Constipation Market Share by Company (2016)
The U.S. Constipation Market Share Forecast by Company (2021)
Ironwood Pharmaceuticals Inc Revenue by Product (2016)
Ironwood Pharmaceutical Inc. Revenue and Net Loss (2012-2016)
Ironwood Pharmaceuticals Inc. R&D Expenditure (2014-2016)
Sucampo Pharmaceuticals Inc. Revenue by Product (2016)
Sucampo Pharmaceuticals Inc. Revenue and Net Income (2012-2016)
Sucampo Pharmaceuticals Inc. R&D Expenditure (2014-2016)
ARDELYX, Inc. Total Revenue and Net Loss (2012-2016)
ARDELYX, Inc. R&D Expenditure (2014-2016)
Synergy Pharmaceuticals, Inc. Net Loss (2012-2016)
Synergy Pharmaceuticals, Inc. R&D Expenditure (2014-2016)
Drugs under Development for Constipation (2016)
ARDELYX, Inc. Drugs Under Pipeline
Synergy Pharmaceuticals, Inc. Drugs Under Pipeline (2016)
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Constipation is a chronic medical condition which makes a person unable to pass fecal content properly. In this condition, the stool is often dry, hard and painful to pass. Bowel movements vary person to person but, if the bowel movement is missing for more than 3 days in adults and 4 days in children, then it is considered as constipation. Constipation can be of three types; irritable bowel syndrome-constipation (IBS-C), chronic idiopathic constipation and opioid-induced-constipation (OIC).
The U.S. is a major contributor to the global constipation market supported by rising opioid usage among chronic disease patients and increasing prescription drugs volumes. The U.S. is likely to experience further growth in constipation market with increasing ageing population and rapid development of new drugs in the market.
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
Purchase a copy of Constipation Market visit @ http://www.orbisresearch.com/contact/purchase/402949 For more information contact sales@orbisresearch.com .
The global constipation market is expected to grow in future with rising constipation prevalence, increasing ageing population, rise in health expenditure, mounting spinal cord injury patient population, growing spending on medicines and pharmaceutical R&D expenditure. Key trends of this market include progressing drugs under pipeline and adoption of unhealthy lifestyle. However, there are some factors which can hinder growth of the market including stringent regulations and low awareness of prescription drugs.
The report “Global Constipation Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., Japan, China and Europe. The report profiles the key players of the market including Ironwood Pharmaceuticals Inc., Sucampo Pharmaceuticals Inc., Synergy Pharmaceuticals Inc. and ARDELYX Inc.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-constipation-market-industry-analysis-and-outlook-2017-2021 .
List Of Tables:
Types of Constipation
Current Treatment Options for Constipation
The U.S. Constipation Market by Value (2012-2016)
The U.S. Constipation Market by Type (2012-2016)
The U.S. Constipation Market Forecast by Value (2017-2021)
The U.S. Constipation Market Forecast by Type (2017-2021)
The U.S. Constipation Market by Drug (2016/2021)
The U.S. Constipation Branded Drugs Prescription Volume (2012-2016)
The U.S. Constipation Branded Drug Prescription Volume by Type (2012-2016)
The U.S. Constipation Patient Population Forecast (2016-2021)
Europe CIC Patient Population Forecast (2016-2021)
Europe IBS-C Patient Population Forecast (2016-2021)
Europe OIC Patient Population Forecast (2016-2021)
Europe Plecanatide Sales Forecast (2018-2021)
Japan Constipation Patient Population Forecast (2016-2021)
Japan Amitiza Sales Forecast (2016-2021)
China Constipation Patient Population Forecast (2016-2021)
China Amitiza Sales Forecast (2018-2021)
Global Ageing Population (2012-2016)
Global Healthcare Expenditure per Capita (2012-2016)
Global Spending on Medicines (2012-2016)
Global Spinal Cord Injury Patient Population (2012-2016)
Global Pharmaceutical R&D Spending (2013-2016)
Revenue Comparison of Key Players (2016)
Market Cap of Key Players (2016)
The U.S. Constipation Market Share by Company (2016)
The U.S. Constipation Market Share Forecast by Company (2021)
Ironwood Pharmaceuticals Inc Revenue by Product (2016)
Ironwood Pharmaceutical Inc. Revenue and Net Loss (2012-2016)
Ironwood Pharmaceuticals Inc. R&D Expenditure (2014-2016)
Sucampo Pharmaceuticals Inc. Revenue by Product (2016)
Sucampo Pharmaceuticals Inc. Revenue and Net Income (2012-2016)
Sucampo Pharmaceuticals Inc. R&D Expenditure (2014-2016)
ARDELYX, Inc. Total Revenue and Net Loss (2012-2016)
ARDELYX, Inc. R&D Expenditure (2014-2016)
Synergy Pharmaceuticals, Inc. Net Loss (2012-2016)
Synergy Pharmaceuticals, Inc. R&D Expenditure (2014-2016)
Drugs under Development for Constipation (2016)
ARDELYX, Inc. Drugs Under Pipeline
Synergy Pharmaceuticals, Inc. Drugs Under Pipeline (2016)
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results